Profilo
Gerard Farmer is currently the Director of Regulatory Affairs at Anergis SA since 2011.
Prior to this, he worked as the Director of Regulatory Affairs at biolitec Pharma Ltd.
and as the Manager of International Regulatory Affairs at Roche Holding AG.
Posizioni attive di Gerard Farmer
| Società | Posizione | Inizio |
|---|---|---|
Anergis SA
 Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland. | Consigliere Generale | 01/06/2011 |
Precedenti posizioni note di Gerard Farmer
| Società | Posizione | Fine |
|---|---|---|
| ROCHE HOLDING AG | Consigliere Generale | - |
biolitec Pharma Ltd.
 biolitec Pharma Ltd. Medical SpecialtiesHealth Technology biolitec Pharma Ltd. produces and markets a photo technology platform for the treatment of head and neck cancer. Its product Foscan, is a porphyrin photosensitising device used for the treatment of head and neck cancer in patients who cannot be treated with other therapies. The company is headquartered in Dublin, Ireland. | Consigliere Generale | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ROCHE HOLDING AG | Health Technology |
| Aziende private | 2 |
|---|---|
biolitec Pharma Ltd.
biolitec Pharma Ltd. Medical SpecialtiesHealth Technology biolitec Pharma Ltd. produces and markets a photo technology platform for the treatment of head and neck cancer. Its product Foscan, is a porphyrin photosensitising device used for the treatment of head and neck cancer in patients who cannot be treated with other therapies. The company is headquartered in Dublin, Ireland. | Health Technology |
Anergis SA
Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Gerard Farmer
